靶向Cx43治疗减少大鼠烧伤损伤中NLRP3炎症小体活化
本研究采用大鼠深二度烧伤模型,评估Cx43反义寡脱氧核苷酸(Cx43asODN)或Cx43半通道阻滞剂Tonabersat对炎症小体活化的抑制作用及其作为烧伤潜在治疗手段的价值。免疫荧光显示两种处理均降低Cx43半通道与缝隙连接表达,并轻度、短暂降低P2X7表达及炎症小体复合物组装与炎症;组织学分析显示治疗组烧伤创面表皮厚度减少、胶原保存改善。结果提示Cx43介导的NLRP3炎症小体通路可能通过P2X7活化参与早期烧伤创面愈合,靶向Cx43可能具有改善愈合结局的潜在治疗作用。
要点
- 大鼠深二度烧伤模型中,Cx43asODN或Tonabersat降低Cx43半通道与缝隙连接表达。
- 两种处理轻度、短暂降低P2X7表达、炎症小体复合物组装及炎症。
- 治疗组烧伤创面表皮厚度减少、胶原保存改善。
核心结论
- 作者认为,Cx43介导的NLRP3炎症小体通路可能通过P2X7活化参与早期烧伤创面愈合,靶向Cx43可能具有改善愈合结局的潜在治疗作用。
研究设计与样本
- 研究采用大鼠深二度烧伤模型,评估Cx43反义寡脱氧核苷酸(Cx43asODN)或Cx43半通道阻滞剂Tonabersat对炎症小体活化的抑制作用及其作为烧伤潜在治疗手段的价值。
主要发现
- 免疫荧光分析显示,Cx43asODN或Tonabersat降低Cx43半通道和缝隙连接表达。
- Cx43asODN或Tonabersat轻度、短暂降低P2X7表达、炎症小体复合物组装及炎症。
- H&E、Masson三色染色和天狼星红定量分析显示,治疗组烧伤创面表皮厚度减少、胶原保存改善。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Burns are dynamic injuries characterized by an initial zone of necrosis that progresses to compromise surrounding tissue. Acute inflammation and cell death are two main factors contributing to burn progression. These processes are modulated by Connexin43 (Cx43) hemichannels and gap junctions in burns and chronic wounds. Particularly, Cx43-mediated ATP release may interact with the P2X7 receptor to activate the NLRP3 inflammasome pathway. This study used a deep partial thickness rat burn model to evaluate the effect of Cx43 antisense oligodeoxynucleotides (Cx43asODN) or the Cx43 hemichannel blocker Tonabersat for the inhibition of inflammasome activation and their use as potential treatments for burn injury. Using immunofluorescence analysis, our data showed that Cx43asODN or Tonabersat reduced Cx43 hemichannel and gap junction expression. Concomitantly, they marginally and transiently reduced P2X7 expression and inflammasome complex assembly and inflammation. Quantitative analysis using H&E, Masson's trichrome & Picrosirus Red revealed reduced epidermal thickness and improved collagen preservation in treated burn wounds. Collectively, our findings suggest a possible involvement of the Cx43-mediated NLRP3 inflammasome pathway via P2X7 activation in early burn wound healing. This indicates that targeting Cx43 may have a potential therapeutic effect to improve healing outcomes.
引用
- Thangaveloo M, Feng J, Phillips AR, et al. Targeted Cx43 therapeutics reduce NLRP3 inflammasome activation in rat burn injury. Burns. 2024. PMID: 39798348. doi:10.1016/j.burns.2024.107358
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。